A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study-Reference-Cited by-全球学者库

A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study

Published:2020 Issue:3 Volume:31 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Shi Tingyan¹^ORCID,Yin Sheng¹^ORCID,Zhu Jianqing²^ORCID,Zhang Ping²^ORCID,Liu Jihong³^ORCID,Xiang Libing¹^ORCID,Zhu Yaping⁴^ORCID,Wu Sufang⁴^ORCID,Chen Xiaojun⁵^ORCID,Wang Xipeng⁶^ORCID,Teng Yincheng⁷^ORCID,Zhu Tao²^ORCID,Yu Aijun²^ORCID,Zhang Yingli²^ORCID,Feng Yanling³^ORCID,Huang He³^ORCID,Bao Wei⁴^ORCID,Li Yanli⁴^ORCID,Jiang Wei⁵^ORCID,Zhang Ping⁶^ORCID,Li Jiarui⁶^ORCID,Ai Zhihong⁷^ORCID,Zhang Wei⁸^ORCID,Jia Huixun⁹^ORCID,Zhang Yuqin¹^ORCID,Jiang Rong¹^ORCID,Zhang Jiejie²^ORCID,Gao Wen²^ORCID,Luan Yuting¹^ORCID,Zang Rongyu¹^ORCID

Affiliation:

1. Ovarian Cancer Program, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai, China.

2. Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, China.

3. Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.

4. Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai, China.

5. Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.

6. Department of Gynecology and Obstetrics, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.

7. Department of Gynecology and Obstetrics, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.

8. Department of Biostatistics, Fudan University, Shanghai, China.

9. Clinical Statistics Center, Shanghai General Hospital, Shanghai, China.

Funder

Clinical Trial Project of Zhongshan Hospital, Fudan University

Publisher

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy

Subject

Obstetrics and Gynaecology,Oncology,General Medicine

Link

https://ejgo.org/pdf/10.3802/jgo.2020.31.e61

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A real-world study of PARP inhibitors in 75 patients with platinum-sensitive recurrent ovarian cancer from China;Frontiers in Oncology;2024-01-08

2. Surgery in Recurrent Ovarian Cancer: A Meta-Analysis;Cancers;2023-07-02

3. The current role of secondary cytoreductive surgery for recurrent ovarian cancer;Frontiers in Oncology;2022-10-21

4. Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis;Journal of Clinical Oncology;2022-05-20

5. Addendum: A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study;Journal of Gynecologic Oncology;2022